We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
CardiNor says it has demonstrated secretoneurin’s potential clinical value in two specific areas — support of patient selection for implantable cardioverter defibrillators and heart failure patient discharge eligibility. Read More
Cosmos Pharmaceuticals’ artificial intelligence (AI)-assisted GI Genius endoscopy module significantly reduced the miss rate of colorectal tumors by two times in a recent clinical trial when used in conjunction with colonoscopy. Read More
The FDA has approved the first generic version of AstraZeneca's Symbicort, a blockbuster drug-device combination product for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Read More
“Previously, surgeons had to choose—stem or stemless—for each surgical case without the option to easily change from one to the other,” the company said. Read More
The breast cancer screening system is designed for use in hospitals, acute care settings, outpatient surgeries and other healthcare facilities. Read More
Illumina has launched its cancer diagnostic test, TruSight Oncology (TSO) Comprehensive (EU), in Europe — calling it the first CE-marked in vitro diagnostic (IVD) kit for comprehensive genomic profiling based on DNA and RNA content. Read More
The FDA has posted a warning on its website against using Apyx Medical’s Renuvion/J-Plasma device for aesthetic dermatology procedures, which has caused burns and other serious adverse events. Read More